NON-INVASIVE DETECTION OF FETAL GENETIC TRAITS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

13557025

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Blood plasma of pregnant women contains fetal and (generally >90%) maternal circulatory extracellular DNA. Most of said fetal DNA contains ≦500 base pairs, said maternal DNA having a greater size. Separation of circulatory extracellular DNA of <500 base pairs results in separation of fetal from maternal DNA. A fraction of a blood plasma or serum sample of a pregnant woman containing, due to size separation (e.g. by chromatography, density gradient centrifugation or nanotechnological methods), extracellular DNA substantially comprising ≦500 base pairs is useful for non-invasive detection of fetal genetic traits (including the fetal RhD gene in pregnancies at risk for HDN; fetal Y chromosome-specific sequences in pregnancies at risk for X chromosome-linked disorders; chromosomal aberrations; hereditary Mendelian genetic disorders and corresponding genetic markers; and traits decisive for paternity determination) by e.g. PCR, ligand chain reaction or probe hybridization techniques, or nucleic acid arrays.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SEQUENOM INC3595 JOHN HOPKINS COURT SAN DIEGO CA 92121

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
HAHN, Sinuhe Liestal, CH 14 898
Holzgreve, Wolfgang Basel, CH 10 876
Li, Ying Basel, CH 869 31412
Zimmermann, Bernhard Los Angeles, US 170 8973

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation